In one study trimethoprim increased the AUC of single-dose repaglinide by about 60% without changing its blood glucose lowering effects.
The UK manufacturers advise that concurrent use should be avoided as the effect of larger doses of both drugs are unknown. However, the US manufacturers suggest that repaglinide dosage adjustments may be necessary. If both drugs are used it would seem prudent to increase the frequency of blood glucose monitoring until the effects are known.
© 2006-2022 Last Updated On: 05/18/2022 (0)
Wait 20 seconds...!!!